from Reuters: Health News https://ift.tt/2yuDtTl
U.S. FDA panel backs Celltrion copycat of Roche blood cancer drug
Celltrion Pharm Inc's biosimilar of Roche Holding AG's blockbuster cancer drug, Rituxan, on Wednesday won unanimous backing from an advisory panel to the U.S. Food and Drug Administration.
from Reuters: Health News https://ift.tt/2yuDtTl
from Reuters: Health News https://ift.tt/2yuDtTl
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment